Percutaneous vertebroplasty (PVP) has proven to be a valuable palliative treatment option for patients with medically refractory painful osteolytic metastases of the spine.
Understanding mechanisms that govern cell fate decisions will lead to developing techniques for induction of human mesenchymal stem cell differentiation to desired cell outcomes and production of an a